1 / 31

Decision Making in the Era of Individualized Treatment in Advanced NSCLC: Highlights From Chicago

Decision Making in the Era of Individualized Treatment in Advanced NSCLC: Highlights From Chicago. Third-Generation EGFR TKIs. EGFR Inhibitors Following Progression on EGFR-Directed Therapy Preliminary Efficacy Comparison. Antiangiogenic Agents in Advanced NSCLC.

morag
Download Presentation

Decision Making in the Era of Individualized Treatment in Advanced NSCLC: Highlights From Chicago

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Decision Making in the Era of Individualized Treatment in Advanced NSCLC:Highlights From Chicago

  2. Third-Generation EGFR TKIs

  3. EGFR Inhibitors Following Progression on EGFR-Directed TherapyPreliminary Efficacy Comparison

  4. Antiangiogenic Agents in Advanced NSCLC

  5. First-line Therapy in Advanced NSCLC

  6. Targeting MET in Advanced NSCLC

  7. Global Phase 3 Trial (METLung)* of Onartuzumab Plus Erlotinib in NSCLCTrial Design

  8. METLung TrialOverall Survival Results

  9. Crizotinib in Advanced MET-amplified NSCLCPatient Eligibility: NSCLC MET Amplification Cohort

  10. Characteristics of Patients With ALK-Positive Disease; Second- Generation ALK Inhibitors

  11. ASCEND-1 Trial: Ceritinib in ALK-Positive Advanced NSCLCBest Percentage Change From Baseline

  12. Immune Checkpoint Inhibitor Therapy in Advanced NSCLC

  13. Abbreviations

  14. Abbreviations (cont)

  15. References

  16. References (cont)

  17. References (cont)

  18. References (cont)

  19. References (cont)

  20. References (cont)

More Related